Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Exercise Interventions, Running Biomechanics and Injury in Novice Runners

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by University of Calgary
Sponsor:
Collaborators:
Biomechanigg Research Ltd.
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Jennifer Baltich, University of Calgary
ClinicalTrials.gov Identifier:
NCT01900262
First received: July 8, 2013
Last updated: April 29, 2014
Last verified: April 2014
  Purpose

The purpose of this study is to understand the effects of muscle strengthening and balance exercise interventions on muscle strength, running mechanics and postural control in novice recreational runners. Participants will be assessed before and after they engage in an 8-week exercise intervention program.


Condition Intervention
Strength
Kinematics
Kinetics
Balance
Injury
Other: Strengthening
Other: Balance Training
Other: Stretching

Study Type: Interventional
Study Design: Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by University of Calgary:

Primary Outcome Measures:
  • Change in Strength [ Time Frame: Week 0, Week 8 ]
    Strength of the muscles crossing the ankle, knee and hip joint will be assessed at baseline and after 8 weeks of training in order to assess the change in strength following training.

  • Change in Running Mechanics [ Time Frame: Week 0, Week 8 ]
    Running kinematics and kinetics will be measured using 3D motion capture technology at baseline and after 8 weeks of training in order to assess the change in running mechanics following training.

  • Change in Postural Control [ Time Frame: Week 0, Week 8 ]
    Postural control will be assessed using single leg stance and the star excursion balance test at baseline and after 8 weeks of training in order to assess the change in postural control following training.


Secondary Outcome Measures:
  • Cumulative Running Related Injuries [ Time Frame: Week 0 through Week 24 ]
    Self-reported running-related injuries will be collected on a weekly basis for a total of 6 months following enrollment in order to quantify the cumulative amount of injuries.


Study Start Date: February 2014
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Strengthening
Novice recreational runners from the Calgary area.
Other: Strengthening
Participants will be asked to complete 8 weeks of isolated ankle strengthening at home.
Experimental: Balance Training
Novice recreational runners from the Calgary area.
Other: Balance Training
Participants will be asked to compete 8 weeks of functional balance training at home.
Experimental: Stretching
Novice recreational runners from the Calgary area.
Other: Stretching
Participants will be asked to complete a standard of practice static and dynamic stretching warm-up for 8 weeks at home.

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Novice recreational runners
  • Less than one year of running experience
  • Run at least twice a week for a total weekly distance between 5 and 15 km as your main form of physical activity
  • 18-50 years of age

Exclusion Criteria:

  • Neurological abnormalities or lower extremity injury or pain within three months of enrollment.
  • No extensive history with balance training or isolated ankle strengthening within the last year.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01900262

Contacts
Contact: Jennifer Baltich, M.Sc. 403-220-5142 jbaltich@kin.ucalgary.ca

Locations
Canada, Alberta
University of Calgary Not yet recruiting
Calgary, Alberta, Canada, T2N1N4
Contact: Jennifer Baltich, M.Sc.    403-220-5142    jbaltich@kin.ucalgary.ca   
Principal Investigator: Jennifer Baltich, B.Sc., M.Sc.         
University of Calgary Recruiting
Calgary, Alberta, Canada, T2N1N4
Contact: Jennifer Baltich, MSc    403-220-5142    jbaltich@kin.ucalgary.ca   
Sub-Investigator: Jennifer Baltich, MSc         
Sponsors and Collaborators
University of Calgary
Biomechanigg Research Ltd.
Canadian Institutes of Health Research (CIHR)
  More Information

No publications provided

Responsible Party: Jennifer Baltich, Doctoral Student, University of Calgary
ClinicalTrials.gov Identifier: NCT01900262     History of Changes
Other Study ID Numbers: RRI2014
Study First Received: July 8, 2013
Last Updated: April 29, 2014
Health Authority: Canada: Ethics Review Committee

ClinicalTrials.gov processed this record on November 20, 2014